Publicacións en colaboración con investigadores/as de University of Münster (14)

2024

  1. Progress on the development of Class A GPCR-biased ligands

    British Journal of Pharmacology

2023

  1. Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists

    Communications biology, Vol. 6, Núm. 1, pp. 376

2022

  1. Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1361-1368

2021

  1. The pi3kδ inhibitor idelalisib diminishes platelet function and shows antithrombotic potential

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

2020

  1. A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

    Thrombosis and Haemostasis, Vol. 120, Núm. 2, pp. 262-276

  2. Covalently and ionically, dually crosslinked chitosan nanoparticles block quorum sensing and affect bacterial cell growth on a cell-density dependent manner

    Journal of Colloid and Interface Science, Vol. 578, pp. 171-183

2019

  1. Effect of the ultrastructure of chitosan nanoparticles in colloidal stability, quorum quenching and antibacterial activities

    Journal of Colloid and Interface Science, Vol. 556, pp. 592-605

  2. Platelet membrane lipid rafts protein composition varies following GPVI and CLEC-2 receptors activation

    Journal of Proteomics, Vol. 195, pp. 88-97

2016

  1. Physical Properties and Stability of Soft Gelled Chitosan-Based Nanoparticles

    Macromolecular Bioscience, Vol. 16, Núm. 12, pp. 1873-1882

2014

  1. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 87, Núm. 1, pp. 47-54

2013

  1. Chitosan-based nanomaterials for drug delivery and antibiotic-free bacterial control

    Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013

  2. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery

    International Journal of Pharmaceutics, Vol. 458, Núm. 1, pp. 83-89

  3. Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles

    International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 115-123

2012

  1. Chitosan-based nanocapsules: Physical characterization, stability in biological media and capsaicin encapsulation

    Colloid and Polymer Science, Vol. 290, Núm. 14, pp. 1423-1434